Lenalidomide, Adriamycin, Dexamethasone (RAD) Versus Lenalidomide, Bortezomib, Dexamethasone (VRD) for Induction in Newly Diagnosed Multiple Myeloma Followed by Response-adapted Consolidation and Lenalidomide Maintenance
Clinical trial NCT01685814 · UNKNOWN
Trial details
- NCT number
- NCT01685814
- Sponsor
- Wuerzburg University Hospital
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-05-01
- Primary completion
- 2016-09-01
- Enrollment
- 406
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.